Annual report pursuant to Section 13 and 15(d)

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail)

v3.19.3.a.u2
Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Schedule Of Cash Flow Supplemental [Line Items]        
Cash paid for interest   $ 93,907 $ 98,411 $ 99,232
Cash paid for income taxes, net of refunds received   88,670 64,199 95,043
Noncash investing and financing activities:        
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment [1]   22,013 (5,728) 9,349
Theatre properties acquired under finance leases   21,535 18,851 46,727
Investment in NCM – receipt of common units (see Note 7) $ 1,552 1,552 5,012 18,363
Dividends accrued on unvested restricted stock unit awards   (670) (624) $ (558)
NCM        
Noncash investing and financing activities:        
Interest expense - NCM (see Notes 4 and 7)   $ (28,624) $ (19,724)  
[1] Additions to theatre properties and equipment included in accounts payable as of December 31, 2018 and 2019 were $37,004 and $14,991, respectively.